"Community Blood Center (CBC), established over 40 years ago, serves hospitals in the Greater Kansas City metropolitan area, as well as eastern Kansas and western Missouri. CBC provides blood products to 70 area hospitals – and relies on volunteer donors each day to meet the need for life-saving gifts of blood. CBC provides high quality reference immunohematology laboratory services, including platelet and red blood cell antibody testing, and therapeutic apheresis to local hospitals."

During the past decade, Community Blood Center of Greater Kansas conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 2 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Community Blood Center of Greater Kansas" are "Healthy Volunteers" (2 trials). Many other conditions were trialed in "Community Blood Center of Greater Kansas" in a lesser frequency.

Most popular intervention types in "Community Blood Center of Greater Kansas" are "Device" (2 trials). Other intervention types were less common.

The name of intervention was led by "Trima Accel System with Version 7.0 Software" (2 trials). Other intervention names were less common.

The vast majority of trials in "Community Blood Center of Greater Kansas" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Community Blood Center of Greater Kansas". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Community Blood Center of Greater Kansas, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Community Blood Center of Greater Kansas, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".